FEASIBILITY OF 3 G M2 OF INTRAVENOUS METHOTREXATE (IVMTX) FOR PRIMARYCENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL)/

Citation
W. Sherman et al., FEASIBILITY OF 3 G M2 OF INTRAVENOUS METHOTREXATE (IVMTX) FOR PRIMARYCENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL)/, Neurology, 48(3), 1997, pp. 1002-1002
Citations number
NO
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
00283878
Volume
48
Issue
3
Year of publication
1997
Supplement
2
Pages
1002 - 1002
Database
ISI
SICI code
0028-3878(1997)48:3<1002:FO3GMO>2.0.ZU;2-4